IGF‐1/SLC25A33 Maintains Blood‐Labyrinth Barrier Integrity by Suppressing TGF‐β/Smad2‐Mediated Pericyte Activation in Age‐Related Hearing Loss
Key claim: IGF-1/SLC25A33 preserves blood-labyrinth barrier integrity in age-related hearing loss by suppressing TGF-β/Smad2-mediated pericyte activation.
Abstract
Aging Cell, Volume 25, Issue 10, October 2026.
Why this matters
Age-related hearing loss has primarily been framed as hair-cell and cochlear-neuron degeneration, but this paper locates a parallel lesion in the cochlear microvasculature: IGF-1 acting through the mitochondrial carrier SLC25A33 keeps pericytes from being activated by TGF-β/Smad2, and loss of that restraint degrades the blood-labyrinth barrier. It connects the systemic GH/IGF-1 aging axis to a specific pericyte-barrier mechanism in a sensory organ, mirroring BBB-pericyte stories already logged for brain aging. The evidence is preclinical pathway detail, not a human-translatable intervention.